Results 141 to 150 of about 47,991 (257)
ABSTRACT Background/Objectives Dupilumab is an anti‐interleukin (IL)‐4 receptor (IL‐4Rα) monoclonal antibody used to manage atopic dermatitis (AD). There is a paucity of real‐world Australian data for dupilumab in paediatric AD, especially regarding differences in clinical profiles between age groups.
Paul Sun Woo Kim +7 more
wiley +1 more source
Prevalence of Chronic Pruritus in Elderly Black and White Inpatients: A Comparative Population Study. [PDF]
Mahmoud O +3 more
europepmc +1 more source
Current Management of Chronic Pruritus by French Dermatologists. [PDF]
Encarnaçao Domingos-Ancement E +2 more
europepmc +1 more source
"Look Beyond the Skin": A case report about chronic pruritus. [PDF]
Quddusi FI, Youssef MJ.
europepmc +1 more source
ABSTRACT Background Skin disease is a major cause of morbidity in Australia and a leading reason for primary care visits. Aboriginal and Torres Strait Islander peoples experience a disproportionate burden of skin conditions but face barriers to accessing culturally safe specialist services.
Nikhil Dwivedi +6 more
wiley +1 more source
European S2k Guideline on Chronic Pruritus [PDF]
Weisshaar E +13 more
europepmc +1 more source
Effect of Anti‐IL‐23 and Anti‐IL‐17 Therapy on Darier Disease: A Case Series
ABSTRACT Darier disease is a rare ATP2A2‐related genodermatosis for which therapeutic options remain limited, as acitretin is often constrained by toxicity and teratogenicity. In this retrospective real‐world case series of eight patients, anti‐IL‐17 therapy showed a more consistent early signal of clinical benefit than anti‐IL‐23 therapy, with greater
Maione Vincenzo +6 more
wiley +1 more source
Reduced Descending Itch Inhibition in Peripheral Neuropathy Patients With Chronic Pruritus. [PDF]
Eck J +9 more
europepmc +1 more source
Neurotrophin-4 and Brain-Derived Neurotrophic Factor Serum Levels in Renal Transplant Recipients with Chronic Pruritus. [PDF]
Tyczyńska K +6 more
europepmc +1 more source
ABSTRACT Hereditary angioedema (HAE) with C1 inhibitor deficiency is a rare disease characterized by unpredictable episodes of tissue swelling (angioedema), which, in most cases, occur first under the age of 18 years, and entail a significant burden of disease not only for the patients but also for their families.
Henriette Farkas +128 more
wiley +1 more source

